Skip to content
Search

Latest Stories

Britain to work with WHO on 'pandemic radar' to track diseases

Britain will work with the World Health Organization (WHO) to develop a "pandemic radar" system to identify new coronavirus variants quickly and track emerging diseases globally to ensure the world is never "caught unawares again".

Prime minister Boris Johnson announced the plan for a new "Global Pandemic Radar" ahead of a G20 Global Health summit on Friday in Rome, where he will speak.


Johnson's office said it would involve a network of surveillance hubs that could watch out for outbreaks and share data on variants and vaccine resistance.

He is using Britain's presidency of the G7 to highlight the need to be prepared for future pandemics, launching an expert group to examine how the development of vaccines against future diseases can be expedited.

"Tackling Covid-19 globally and ensuring we are better prepared for future health threats is an absolute priority for the UK’s G7 presidency," Johnson said.

"The world must never be caught unawares again by a virus spreading among us unchecked. We need to build a system of disease surveillance fit for the 21st century, with real-time data sharing and rapid genomic sequencing and response."

Britain will host a G7 health ministers summit on June 3-4, ahead of an in-person leaders summit in south-west England the following week.

Britain has extensive virus-sequencing capabilities that have come to the fore as coronavirus variants increasingly raise the risk of new waves of infections.

WHO Director-General Tedros Adhanom Ghebreyesus said Britain had "set a strong example for pathogen surveillance and sequencing, as well as vaccine development."

"I am delighted that under PM Johnson, the UK will partner with WHO to contribute to stronger global surveillance and a safer world," he said.

At Friday's summit, leaders of the world's largest economies will adopt a declaration recommending voluntary actions to boost Covid-19 vaccine production, snubbing a push from the United States and other nations on patent waivers, the final text shows.

Drugmakers are also set to announce they will provide large supplies of at-cost Covid-19 vaccines to poor nations this year to try to redress a global imbalance, an EU official said.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less